IBDEI0TT ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13712,2)
 ;;=^5005943
 ;;^UTILITY(U,$J,358.3,13713,0)
 ;;=H43.23^^80^763^28
 ;;^UTILITY(U,$J,358.3,13713,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13713,1,3,0)
 ;;=3^Crystalline Deposits in Vitreous Body,Bilateral
 ;;^UTILITY(U,$J,358.3,13713,1,4,0)
 ;;=4^H43.23
 ;;^UTILITY(U,$J,358.3,13713,2)
 ;;=^5005944
 ;;^UTILITY(U,$J,358.3,13714,0)
 ;;=H43.11^^80^763^117
 ;;^UTILITY(U,$J,358.3,13714,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13714,1,3,0)
 ;;=3^Vitreous Hemorrhage,Right Eye
 ;;^UTILITY(U,$J,358.3,13714,1,4,0)
 ;;=4^H43.11
 ;;^UTILITY(U,$J,358.3,13714,2)
 ;;=^5005938
 ;;^UTILITY(U,$J,358.3,13715,0)
 ;;=H43.12^^80^763^116
 ;;^UTILITY(U,$J,358.3,13715,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13715,1,3,0)
 ;;=3^Vitreous Hemorrhage,Left Eye
 ;;^UTILITY(U,$J,358.3,13715,1,4,0)
 ;;=4^H43.12
 ;;^UTILITY(U,$J,358.3,13715,2)
 ;;=^5005939
 ;;^UTILITY(U,$J,358.3,13716,0)
 ;;=H43.391^^80^763^120
 ;;^UTILITY(U,$J,358.3,13716,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13716,1,3,0)
 ;;=3^Vitreous Opacities,Right Eye NEC
 ;;^UTILITY(U,$J,358.3,13716,1,4,0)
 ;;=4^H43.391
 ;;^UTILITY(U,$J,358.3,13716,2)
 ;;=^5005949
 ;;^UTILITY(U,$J,358.3,13717,0)
 ;;=H43.392^^80^763^119
 ;;^UTILITY(U,$J,358.3,13717,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13717,1,3,0)
 ;;=3^Vitreous Opacities,Left Eye NEC
 ;;^UTILITY(U,$J,358.3,13717,1,4,0)
 ;;=4^H43.392
 ;;^UTILITY(U,$J,358.3,13717,2)
 ;;=^5005950
 ;;^UTILITY(U,$J,358.3,13718,0)
 ;;=H43.393^^80^763^118
 ;;^UTILITY(U,$J,358.3,13718,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13718,1,3,0)
 ;;=3^Vitreous Opacities,Bilateral NEC
 ;;^UTILITY(U,$J,358.3,13718,1,4,0)
 ;;=4^H43.393
 ;;^UTILITY(U,$J,358.3,13718,2)
 ;;=^5005951
 ;;^UTILITY(U,$J,358.3,13719,0)
 ;;=H43.01^^80^763^123
 ;;^UTILITY(U,$J,358.3,13719,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13719,1,3,0)
 ;;=3^Vitreous Prolapse,Right Eye
 ;;^UTILITY(U,$J,358.3,13719,1,4,0)
 ;;=4^H43.01
 ;;^UTILITY(U,$J,358.3,13719,2)
 ;;=^5005934
 ;;^UTILITY(U,$J,358.3,13720,0)
 ;;=H43.02^^80^763^122
 ;;^UTILITY(U,$J,358.3,13720,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13720,1,3,0)
 ;;=3^Vitreous Prolapse,Left Eye
 ;;^UTILITY(U,$J,358.3,13720,1,4,0)
 ;;=4^H43.02
 ;;^UTILITY(U,$J,358.3,13720,2)
 ;;=^5005935
 ;;^UTILITY(U,$J,358.3,13721,0)
 ;;=H43.03^^80^763^121
 ;;^UTILITY(U,$J,358.3,13721,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13721,1,3,0)
 ;;=3^Vitreous Prolapse,Bilateral
 ;;^UTILITY(U,$J,358.3,13721,1,4,0)
 ;;=4^H43.03
 ;;^UTILITY(U,$J,358.3,13721,2)
 ;;=^5005936
 ;;^UTILITY(U,$J,358.3,13722,0)
 ;;=H43.821^^80^763^115
 ;;^UTILITY(U,$J,358.3,13722,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13722,1,3,0)
 ;;=3^Vitreomacular Adhesion,Right Eye
 ;;^UTILITY(U,$J,358.3,13722,1,4,0)
 ;;=4^H43.821
 ;;^UTILITY(U,$J,358.3,13722,2)
 ;;=^5005957
 ;;^UTILITY(U,$J,358.3,13723,0)
 ;;=H43.822^^80^763^114
 ;;^UTILITY(U,$J,358.3,13723,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13723,1,3,0)
 ;;=3^Vitreomacular Adhesion,Left Eye
 ;;^UTILITY(U,$J,358.3,13723,1,4,0)
 ;;=4^H43.822
 ;;^UTILITY(U,$J,358.3,13723,2)
 ;;=^5005958
 ;;^UTILITY(U,$J,358.3,13724,0)
 ;;=H43.823^^80^763^113
 ;;^UTILITY(U,$J,358.3,13724,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13724,1,3,0)
 ;;=3^Vitreomacular Adhesion,Bilateral
 ;;^UTILITY(U,$J,358.3,13724,1,4,0)
 ;;=4^H43.823
 ;;^UTILITY(U,$J,358.3,13724,2)
 ;;=^5005959
 ;;^UTILITY(U,$J,358.3,13725,0)
 ;;=H35.31^^80^763^63
 ;;^UTILITY(U,$J,358.3,13725,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13725,1,3,0)
 ;;=3^Nonexudative Age-Related Macular Degeneration
 ;;^UTILITY(U,$J,358.3,13725,1,4,0)
 ;;=4^H35.31
